Celgene European Investment Co LLC's Net Worth
$163 Million
Who is Celgene European Investment Co LLC?
Celgene European Investment Co LLC has an estimated net worth of $163 Million. This is based on reported shares across multiple companies, which include AGIOS PHARMACEUTICALS INC, and Epizyme, Inc..
SEC CIK
Celgene European Investment Co LLC's CIK is 0001577650
Past Insider Trading and Trends
2013 was Celgene European Investment Co LLC's most active year for acquiring shares with 4 total transactions. Celgene European Investment Co LLC's most active month to acquire stocks was the month of May. 2013 was Celgene European Investment Co LLC's most active year for disposing of shares, totalling 3 transactions. Celgene European Investment Co LLC's most active month to dispose stocks was the month of June. 2014 saw Celgene European Investment Co LLC paying a total of $9,945,000.00 for 340,000 shares, this is the most they've acquired in one year. In 2013 Celgene European Investment Co LLC cashed out on 20,833,969 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AGIOS PHARMACEUTICALS INC (AGIO) Snapshot price: $43.28
InvestorCelgene European Investment Co LLC owns 4,010,926 units of Common Stock which is worth $173,592,877.28.acquired a total of 4,010,926 shares in AGIOS PHARMACEUTICALS INC.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +29.33% | 403.23K |
$31.00 | $12,499,975.00 | 1.78M |
Nov 12
| |||
Form 4/A
| +162.61% | 851.15K |
$67.00 | $57,027,318.00 | 1.37M |
Jan 23
| |||
Form 4
| +162.61% | 851.15K |
$67.00 | $57,027,318.00 | 1.37M |
Jan 23
| |||
Form 4
| +50.71% | 624.58K |
$49.50 | $30,916,462.50 | 1.86M |
Apr 24
| |||
Form 4
| +22.79% | 228.65K |
$110.75 | $25,322,433.75 | 1.23M |
Dec 16
| |||
Form 4
| +41.62% | 294.8K |
$44.00 | $12,971,200.00 | 1M |
Apr 29
| |||
Form 4
|
∞
| 4.72M |
$18.00 | $12,749,994.00 | 4.72M |
Jul 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Epizyme, Inc. No price found
InvestorCelgene European Investment Co LLC owns 3,674,640 units of Common Stock. In the year 2013 Celgene European Investment Co LLC filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.20% | 340K |
$29.25 | $9,945,000.00 | 3.67M |
Feb 10
| |||
Form 4
|
∞
| 3.33M |
$15.00 |
—
| 3.33M |
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||